Key Laboratory of Bio-Resources and Eco-Environment of Ministry of Education, College of Life Sciences, Sichuan University, Chengdu, 610065, Sichuan, People's Republic of China.
Bio-Resource Research and Utilization Joint Key Laboratory of Sichuan and Chongqing, Chongqing Nanchuan Biotechnology Research Institute, Chongqing, Sichuan, People's Republic of China.
Virol J. 2021 Apr 8;18(1):72. doi: 10.1186/s12985-021-01528-w.
Human papillomavirus type 39 associated with genital intraepithelial neoplasia and invasive cancers, has a high prevalence in Southwest China. HPV E6, E7 are two main papillomavirus oncoproteins, closely relate to the function of HPV immortalization, cell transformation, and carcinogenesis. L1 is the major capsid protein, can reflect the replication status of the virus in cells and the progression of cervical lesions. The purpose of this study is to reveal the prevalence of HPV 39 and the genetic polymorphisms of HPV39 based on E6, E7 and L1 gene in southwest China.
Cell samples were collected by cervical scraped for HPV detecting and typing, and HPV39 positive samples were selected out. Important E6, E7 and L1 genes of HPV39 were sequenced and analyzed for the study of HPV39 genetic polymorphisms. Phylogenetic trees were constructed by Maximum-likelihood and Kimura 2-parameters methods in Molecular Evolutionary Genetics Analysis version 6.0. The selection pressures of E6, E7 and L1 genes were estimated by Datamonkey web server. The secondary and three-dimensional structure of HPV39 E6, E7 proteins were created by sopma server and SWISS-MODEL software.
344 HPV39 positive samples were selected from 5718 HPV positive cell samples. Among HPV39 E6-E7 sequences, 20 single nucleotide mutations were detected, including 10 non-synonymous and 10 synonymous mutations; 26 single nucleotide mutations were detected in HPV39 L1 sequences, including 7 non-synonymous and 19 synonymous mutations respectively. 11 novel variants of HPV39 E6-E7 (5 in E6 and 6 in E7) and 14 novel variants of HPV39 L1 were identified in this study. A-branch was the most frequent HPV39 lineage in southwest China during our investigation. Selective pressure analysis showed that codon sites 26, 87, 151 in E6 and 75, 180, 222, 272, 284, 346, 356 in L1 were positively selected sites, as well as codon sites 45, 138, 309, 381 were negative selection sites in L1 gene, E7 has neither positive selection sites nor negative selection sites. A certain degree of secondary and three-dimensional structure dislocation was existed due to the non-synonymous mutations.
Amino acid substitution affected the secondary and three-dimensional structure of HPV39, and resulting in the differences of carcinogenic potential and biological functions as well as the immune response due to the antigen epitopes difference, the antigen epitopes with stronger adaptability in Southwest will be screened out based on the above research results for the later vaccine development. And gene polymorphism of HPV39 in Southwest China may improve the effectiveness of clinical test and vaccine design, specifically for women in Southwest China.
人乳头瘤病毒 39 型与生殖器上皮内瘤变和浸润性癌症有关,在中国西南部流行率较高。HPV E6、E7 是两种主要的乳头瘤病毒致癌蛋白,与 HPV 永生化、细胞转化和致癌作用密切相关。L1 是主要的衣壳蛋白,可反映病毒在细胞中的复制状态和宫颈病变的进展。本研究旨在揭示中国西南部 HPV39 的流行情况及基于 E6、E7 和 L1 基因的 HPV39 基因多态性。
通过宫颈刮片采集细胞样本进行 HPV 检测和分型,选择 HPV39 阳性样本。对 HPV39 的重要 E6、E7 和 L1 基因进行测序和分析,以研究 HPV39 的遗传多态性。采用最大似然法和 Kimura 2-参数法在 Molecular Evolutionary Genetics Analysis version 6.0 中构建系统发育树。利用 Datamonkey web 服务器估计 E6、E7 和 L1 基因的选择压力。利用 sopma 服务器和 SWISS-MODEL 软件构建 HPV39 E6、E7 蛋白的二级和三维结构。
从 5718 例 HPV 阳性细胞样本中选择了 344 例 HPV39 阳性样本。在 HPV39 E6-E7 序列中,检测到 20 个单核苷酸突变,包括 10 个非同义突变和 10 个同义突变;在 HPV39 L1 序列中检测到 26 个单核苷酸突变,包括 7 个非同义突变和 19 个同义突变。本研究在 HPV39 E6-E7 中鉴定了 11 种新的 HPV39 变异体(5 种在 E6 中,6 种在 E7 中)和 14 种 HPV39 L1 的新变异体。在本研究中,A 分支是中国西南部 HPV39 最常见的谱系。选择压力分析表明,E6 中的密码子 26、87、151 和 L1 中的 75、180、222、272、284、346、356 是阳性选择位点,而 L1 基因中的密码子 45、138、309、381 是阴性选择位点,E7 既没有阳性选择位点也没有阴性选择位点。由于非同义突变,一定程度上改变了 HPV39 的二级和三维结构。
氨基酸取代影响 HPV39 的二级和三维结构,由于抗原表位的差异导致致癌潜力和生物学功能以及免疫反应的差异,基于上述研究结果,将筛选出在西南地区具有更强适应性的抗原表位,用于以后的疫苗开发。中国西南部 HPV39 的基因多态性可能会提高临床检测和疫苗设计的有效性,特别是针对中国西南部的女性。